Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Predicting future rates of tau accumulation on PET
Clifford R. Jack, Heather J. Wiste, Stephen D. Weigand, et al.
Brain (2020) Vol. 143, Iss. 10, pp. 3136-3150
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Biomarkers for neurodegenerative diseases
Oskar Hansson
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 954-963
Open Access | Times Cited: 743
Four distinct trajectories of tau deposition identified in Alzheimer’s disease
Jacob W. Vogel, Alexandra L. Young, Neil P. Oxtoby, et al.
Nature Medicine (2021) Vol. 27, Iss. 5, pp. 871-881
Open Access | Times Cited: 551
The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics
Eric Karran, Bart De Strooper
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 4, pp. 306-318
Open Access | Times Cited: 498
Structural progression of Alzheimer’s disease over decades: the MRI staging scheme
Vincent Planche, José V. Manjón, Boris Mansencal, et al.
Brain Communications (2022) Vol. 4, Iss. 3
Open Access | Times Cited: 82
Predicting amyloid PET and tau PET stages with plasma biomarkers
Clifford R. Jack, Heather J. Wiste, Alicia Algeciras‐Schimnich, et al.
Brain (2023) Vol. 146, Iss. 5, pp. 2029-2044
Open Access | Times Cited: 76
Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals
Davina Biel, Matthias Brendel, Anna Rubinski, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 104
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
Antoine Leuzy, Ruben Smith, Nicholas Cullen, et al.
JAMA Neurology (2021) Vol. 79, Iss. 2, pp. 149-149
Open Access | Times Cited: 102
Lipid Profiling of Alzheimer’s Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism
Sümeyya Akyol, Zafer Ugur, Ali Yilmaz, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2591-2591
Open Access | Times Cited: 82
Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer’s disease
Amelia Strom, Leonardo Iaccarino, Lauren Edwards, et al.
Brain (2021) Vol. 145, Iss. 2, pp. 713-728
Open Access | Times Cited: 70
Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer’s disease
Jeremy A. Tanner, Leonardo Iaccarino, Lauren Edwards, et al.
Brain (2022) Vol. 145, Iss. 12, pp. 4489-4505
Open Access | Times Cited: 51
Tau-PET imaging predicts cognitive decline and brain atrophy progression in early Alzheimer’s disease
Julien Lagarde, Pauline Olivieri, Mattéo Tonietto, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 93, Iss. 5, pp. 459-467
Open Access | Times Cited: 43
CSF biomarkers and plasma p‐tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design
Alexis Moscoso, Thomas K. Karikari, Michel J. Grothe, et al.
Alzheimer s & Dementia (2022) Vol. 18, Iss. 12, pp. 2614-2626
Open Access | Times Cited: 40
A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer’s Disease Continuum
Emma M. Coomans, Inge M.W. Verberk, Rik Ossenkoppele, et al.
Journal of Nuclear Medicine (2022) Vol. 64, Iss. 3, pp. 437-443
Open Access | Times Cited: 39
Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis
Diana I. Bocancea, Anna L. Svenningsson, Anna C. van Loenhoud, et al.
Brain (2023) Vol. 146, Iss. 9, pp. 3719-3734
Open Access | Times Cited: 24
Delayed primacy recall in AVLT is associated with medial temporal tau PET burden in cognitively unimpaired adults
Ainara Jauregi Zinkunegi, Tobey J. Betthauser, Cynthia M. Carlsson, et al.
Cortex (2025) Vol. 184, pp. 47-57
Open Access | Times Cited: 1
Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease
Gillian Coughlan, Hannah M Klinger, Rory Boyle, et al.
JAMA Neurology (2025)
Closed Access | Times Cited: 1
Associations between hormone therapy use and tau accumulation in brain regions vulnerable to Alzheimer’s disease
Gillian Coughlan, Zoe B. Rubinstein, Hannah M Klinger, et al.
Science Advances (2025) Vol. 11, Iss. 10
Open Access | Times Cited: 1
KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease
Julia Neitzel, Nicolai Franzmeier, Anna Rubinski, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 48
Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study
Justin S. Sanchez, Bernard Hanseeuw, Francisco Lopera, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 45
Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals
Colin Groot, Ruben Smith, Erik Stomrud, et al.
Brain (2022) Vol. 146, Iss. 4, pp. 1580-1591
Open Access | Times Cited: 35
Network Tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes
Víctor Montal, Ibai Díez, Chan Mi Kim, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 655
Open Access | Times Cited: 33
Rates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL 18F-MK6240 PET study
Natasha Krishnadas, Vincent Doré, Joanne Robertson, et al.
EBioMedicine (2023) Vol. 88, pp. 104450-104450
Open Access | Times Cited: 21
Association of APOE -ε4, Osteoarthritis, β-Amyloid, and Tau Accumulation in Primary Motor and Somatosensory Regions in Alzheimer Disease
Jing Du, Anqi Li, Dai Shi, et al.
Neurology (2023) Vol. 101, Iss. 1
Open Access | Times Cited: 21
Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease
Yue Cai, Jing Du, Anqi Li, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 20
Longitudinal amyloid and tau PET imaging in Alzheimer's disease: A systematic review of methodologies and factors affecting quantification
Ariane Bollack, Hugh Pemberton, Lyduine E. Collij, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 5232-5252
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top